04 April 2018
An alternative method for monitoring dogs that are being treated for Cushing’s syndrome has been launched by Dechra Veterinary Products.
Pre-Vetoryl Cortisol (PVC) monitoring information, which has been developed with Professor Ian Ramsey at the University of Glasgow, is now available at www.dechra.co.uk/prevetorylcortisol
Alongside the new monitoring tools, the site contains a suite of other useful resources for patients on Vetoryl®.
The improved monitoring method has been introduced following recent studies that showed a lack of correlation between ACTH stimulation test results and the clinical status of dogs treated with Vetoryl 1,2
PVC monitoring emphasises the importance of consulting with the owners regarding the dog’s clinical response at home and is suitable for most dogs.
Craig Sankey, Brand Manager at Dechra Veterinary Products, said: “Vetoryl is a medicine that will normally deliver major clinical benefits to a patient with canine Cushing's syndrome but finding a stable, long-term dosing regimen can be hard if ACTH stimulation tests return varying results.
“Pre-Vetoryl Cortisol monitoring is a reliable alternative to traditional ACTH stimulation tests for several reasons. It predicts clinical signs better, gives more consistent results, is less expensive and is easier to perform.
“Our online guide gives veterinary professionals a detailed insight into how they can integrate PVC into their treatment plans and the benefits it can bring to their patients and practice.”
Dechra also hosts a dedicated website for owners whose pets have been prescribed Vetoryl, to help them understand the condition and monitor their progress at www.canine-cushings.co.uk.
Dechra launches improved monitoring method for Cushingoid dogs